Ultralife CORP: directors' dealings · United States · SEC (Form 4)

About Ultralife CORP

Ultralife Corp. (ticker: ULBI) is a U.S.-based industrial company listed on the NASDAQ Global Market in the United States. The company develops and manufactures mission-critical battery and RF power and communications solutions for government, defense, industrial, and commercial customers. Its corporate headquarters is in Newark, New York, where it also maintains a major operating and manufacturing footprint. The company traces its modern origins to 1991, when it came public out of the battery activities associated with Kodak’s Ultra Technologies division. Since then, Ultralife has expanded through a mix of internal development and targeted acquisitions. Ultralife reports its operations in two core segments: Battery & Energy Products and Communications Systems. Battery & Energy Products includes lithium 9-volt, cylindrical, thin-cell, and other non-rechargeable batteries, as well as rechargeable batteries, uninterruptible power supplies, charging systems, and related accessories. Communications Systems covers RF amplifiers, power supplies, cable and connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, integrated communication systems for fixed and vehicle applications, and systems engineering services. This product mix places Ultralife in a specialized niche rather than in commodity batteries, with revenues tied to technical applications where reliability, performance, and custom engineering matter more than price alone. From a competitive standpoint, the company positions itself as a mission-critical solutions provider with strong engineering capabilities, application-specific customization, and a diversified portfolio across power and communications end markets. It serves customers across North America, Europe, and Asia, supported by development and manufacturing resources in multiple regions. The company also markets products under several brands, including Ultralife, Accutronics, Electrochem, Excell, and SWE. Recent strategic developments have been important. In October 2024, Ultralife completed its acquisition of Electrochem Solutions, strengthening its battery manufacturing capabilities and broadening its exposure to energy, military, and industrial applications. In its 2025 annual report, management said it realigned several thionyl chloride/oil & gas operations into a single business within Battery & Energy Products to optimize synergies and deepen customer engagement. The company also reported backlog of about $110 million at the end of 2025, up sequentially, which points to improved near-term visibility and stronger order flow. For investors, ULBI remains a niche industrial name with meaningful exposure to defense, specialty energy storage, and communication systems. The business is highly dependent on contract timing, product mix, and execution, but its acquisition-led expansion and backlog growth indicate a company seeking to build scale and improve profitability over time.